Home> Products> metastatic castration resistant prostate cancer

{ "products": [ { "_id": "6662e4df2bed1f08484d7249", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 160 mg Tablet", "description": "ENZULAMIDE 160\nEnzalutamide 160mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, specifically designed to inhibit androgen receptor signaling at multiple levels, slowing cancer progression even in castration-resistant cases. This oral medication, typically taken as a single daily 160mg dose (four 40mg capsules), binds directly to the androgen receptor, preventing nuclear translocation and DNA binding, which starves hormone-dependent prostate tumors of growth signals. Patients with metastatic castration-resistant prostate cancer (mCRPC), non-metastatic CRPC (nmCRPC), or metastatic castration-sensitive prostate cancer (mCSPC) benefit from its ability to delay disease advancement, reduce PSA levels, and extend progression-free survival.​\n\nAdministered continuously without cycling, enzalutamide 160mg maintains steady-state plasma levels for consistent anti-tumor activity, making it suitable for long-term management alongside standard care. Its role expands beyond initial hormone therapy failures, offering hope where traditional options falter.​\n\nProduct Uses: Targeting Advanced Prostate Cancer\nEnzalutamide 160mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) post-chemotherapy or in pre-chemo settings, where tumors grow despite low testosterone. It excels in non-metastatic CRPC (nmCRPC) by delaying metastasis onset, with trials showing median metastasis-free survival exceeding 3 years versus placebo. In mCSPC, combination with ADT prolongs overall survival by months, reducing radiographic progression risks.​\n\nClinicians prescribe it for high-risk patients with rising PSA despite androgen deprivation therapy (ADT), as it shrinks tumors, alleviates bone pain from metastases, and improves quality of life metrics like urinary function and fatigue scores. Regular monitoring via PSA doubling time and imaging guides ongoing use.​\n\nKey Benefits of Enzalutamide 160mg\nEnzalutamide 160mg delivers transformative outcomes through potent androgen blockade:\n\nExtended Progression-Free Survival: PROSPER trial data indicate 97% risk reduction in metastasis or death for nmCRPC; ENZAMET shows 33% overall survival benefit in mCSPC.​\n\nPSA Response Rates: Over 78% achieve ≥50% PSA decline in mCRPC, correlating with radiographic stability and symptom palliation.​\n\nBone Metastasis Control: Lowers skeletal-related events by 30-40%, preserving mobility and reducing fracture incidence when paired with bone agents.​\n\nQuality of Life Preservation: FACT-P scores improve in pain, appetite, and emotional well-being domains, enabling patients to maintain daily activities longer.​\n\nOral Convenience: Once-daily dosing without food restrictions enhances adherence compared to infusions or multi-pill regimens.​\n\nThese advantages position enzalutamide 160mg as a cornerstone in modern prostate cancer protocols, particularly for fit patients tolerating its profile.​\n\nSide Effects: Managing Risks Effectively\nWhile effective, enzalutamide 160mg carries side effects from androgen suppression and receptor antagonism, affecting 70-90% of users to varying degrees. Most prove manageable with supportive care, dose holds, or adjustments, but vigilance remains essential.​\n\nCommon Side Effects\nFrequently reported (≥10%) issues include:\n\nFatigue/Asthenia (30-40%): Profound tiredness impacting daily tasks; rest, exercise, and stimulants like modafinil help.​\n\nHot Flashes (20-25%): Sudden heat waves; cooling strategies and SSRIs alleviate symptoms.​\n\nMusculoskeletal Pain (15-30%): Joint/muscle aches; NSAIDs or physical therapy provide relief.​\n\nDiarrhea/Constipation (10-20%): Alternating bowel changes; fiber, hydration, and laxatives balance gut function.​\n\nHypertension (10-15%): Blood pressure elevations; routine monitoring and antihypertensives control spikes.​\n\nThese transient effects often peak in first months, diminishing with acclimation.​\n\nSerious Side Effects\nSeek immediate care for:\n\nSeizures (1-2%): Risk higher with brain history; anticonvulsants or discontinuation advised.​\n\nFalls/Fractures (10-15%): Due to weakness, dizziness; fall precautions and bone density scans mitigate.​\n\nCardiovascular Events: Myocardial infarction, strokes (2-5%); lipid/BP checks essential.​\n\nPosterior Reversible Encephalopathy Syndrome (PRES): Rare confusion, seizures, vision loss; MRI confirms.​\n\nSevere Skin Reactions: Stevens-Johnson syndrome; rash monitoring critical.​\n\nBaseline neurological assessments and quarterly labs optimize safety.​\n\nDosage and Administration Guidelines\nSwallow four 40mg capsules whole once daily at the same time, with or without food, totaling 160mg. No dose reductions below 120mg recommended; hold for grade 3-4 toxicity, resuming at prior dose once resolved. Hepatic impairment (Child-Pugh B/C) warrants caution; renal adjustments unnecessary. Continue indefinitely unless progression or intolerance occurs.​\n\nPrecautions and Monitoring\nAvoid in seizure history without prophylaxis; women (especially pregnant) must not handle due to teratogenicity. Strong CYP2A4 inducers/inhibitors alter exposure—adjust accordingly. Elderly patients face amplified fall risks; annual DEXA scans track bone health. Regular PSA, testosterone, CBC, liver enzymes, and ECGs ensure proactive management.​\n\nConclusion\nEnzalutamide 160mg stands as a pivotal advancement in prostate cancer care, offering substantial delays in disease progression, symptom control, and survival gains for patients facing hormone-resistant stages. By meticulously balancing its robust benefits against manageable side effects through vigilant monitoring and supportive measures, individuals regain control over their health journey. Consult oncologists to integrate this therapy seamlessly, tailoring it to personal profiles for optimal, life-extending results\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n", "price": 5531.0, "discountamount": 1660.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "mCRPC", "growth", "doctor", "Dosage", "action", "fatigue", "product", "WhatsApp", "patients", "androgens", "ENZULAMIDE", "hot flashes", "information", "Enzalutamide", "sterisonline", "sterispharma", "cancer cells", "hypertension", "male hormones", "administration", "health condition", "Common side effects", "comprehensive advice", "healthcare professional", "potent anti-androgen medication", "metastatic castration-resistant prostate cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1528, "imageuri": "https://productimages.withfloats.com/actual/667d2980c303c6d6ad1360bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2980c303c6d6ad1360bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:45:51.202Z", "updatedon": "2026-03-12T07:58:25.307Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/enzalutamide-160-mg-tablet/1528", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 160", "category": "Oncology", "tags": [ "enzalutamide 160 mg price in india", "enzalutamide 160 mg uses", "", "enzalutamide 160 mg side effects", "prostate cancer", "prostate tumors of growth signals", "metastatic castration-resistant prostate cancer", "enzalutamide 160 mg tablet uses", "enzalutamide 160 mg tablet dosage", "enzalutamide 160 mg tablet price in india", "enzalutamide 160 mg tablet composition", "enzalutamide 160 mg tablet benefits", "enzalutamide 160 mg tablet side effects", "enzalutamide 160 mg tablet how it works", "enzalutamide 160 mg tablet mechanism of action", "enzalutamide tablets 160 mg information", "enzalutamide 160 mg tablet cost", "enzalutamide 160 mg tablet supplier india", "enzalutamide 160 mg tablet manufacturer", "enzalutamide 160 mg tablet wholesale price", "enzalutamide 160 mg tablet availability in india", "what is enzalutamide 160 mg tablet", "enzalutamide 160 mg tablet treatment use", "enzalutamide 160 mg tablet precautions", "enzalutamide 160 mg tablet alternatives", "enzalutamide 160 mg tablet substitute", "enzalutamide 160 mg tablet india", "enzalutamide 160 mg tablet near me", "enzalutamide 160 mg tablet online india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e3b87247ae19c482b97c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 40mg", "description": "Enzalutamide 40 mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, particularly in metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). This second-generation androgen receptor inhibitor works by disrupting multiple steps in the androgen signaling pathway, offering patients a chance to slow disease progression, reduce tumor burden, and extend survival even after other treatments fail. Administered as a once-daily oral capsule, enzalutamide 40 mg provides four capsules per day (total 160 mg), making it convenient for long-term use in clinical settings where hormone therapy alone proves insufficient.​\n\nPatients often turn to enzalutamide when facing rising PSA levels despite androgen deprivation therapy (ADT), experiencing bone pain, or dealing with cancer spread to lymph nodes or distant sites. Its high affinity for androgen receptors—5-8 times stronger than first-generation antiandrogens like bicalutamide—ensures potent blockade without agonist activity, translating to real-world benefits like delayed chemotherapy needs and improved quality of life during treatment.​\n\nProduct Use and Indications\nEnzalutamide 40 mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) in patients previously treated with docetaxel or progressing despite ADT. The FDA and EMA approvals extend to non-metastatic CRPC (nmCRPC) with high-risk biochemical recurrence and metastatic castration-sensitive prostate cancer (mCSPC) alongside ADT, based on landmark trials like AFFIRM, PREVAIL, PROSPER, and ARCHES.​\n\nKey uses include:\n\nSlowing tumor growth in hormone-refractory stages by inhibiting androgen-driven proliferation.\n\nReducing skeletal-related events like fractures or spinal cord compression in bone metastases.\n\nDelaying progression to chemotherapy in pre-chemotherapy mCRPC, with PREVAIL showing 17-month median radiographic progression-free survival (rPFS) versus 4 months for placebo.​\n\nIn mCSPC, ARCHES trial data demonstrated 61% risk reduction in progression or death when combined with ADT. Clinicians monitor PSA response (≥50% decline in 70-80% of patients) and imaging every 3 months to assess efficacy.​\n\nMechanism of Action\nEnzalutamide 40 mg exerts a threefold blockade on androgen receptor (AR) signaling: it competitively inhibits androgen binding to AR (with affinity rivaling dihydrotestosterone), prevents nuclear translocation of the ligand-receptor complex, and disrupts DNA binding and coactivator recruitment at androgen response elements. This comprehensive inhibition downregulates oncogenes like TMPRSS2-ERG fusion genes common in prostate cancer, inducing apoptosis and halting cell proliferation without lowering systemic testosterone levels.​\n\nUnlike earlier antiandrogens, enzalutamide avoids partial agonist effects, ensuring pure antagonism even in AR-overexpressing tumors. Its active metabolite, N-desmethyl enzalutamide (via CYP2C8), contributes 30% to activity, with steady-state levels achieved in 4 weeks.​\n\nKey Benefits\nExtended Progression-Free Survival: In PREVAIL (pre-chemo mCRPC), median overall survival reached 32.4 months versus 30.2 for placebo; PROSPER (nmCRPC) delayed metastasis by 22 months.​\n\nPSA Response and Tumor Shrinkage: 78% PSA90 response rate; radiographic responses in 29% with measurable disease.​\n\nQuality of Life Preservation: Delays pain progression (hazard ratio 0.40) and chemotherapy (by 17 months), maintaining daily function.​\n\nBone Protection: Reduces fractures by 30% in high-risk patients via AR inhibition in osteoblasts.​\n\nCombination Synergy: Enhances ADT efficacy in mCSPC, cutting death risk by 33% per ARCHES.​\n\nThese benefits position enzalutamide 40 mg as a cornerstone in modern prostate cancer protocols, especially for fit patients tolerating oral therapy.​\n\nSide Effects\nEnzalutamide 40 mg carries a manageable profile, with most effects dose-related and reversible upon discontinuation.\n\nCommon Side Effects\nFatigue/Asthenia (34-50%): Often mild, peaking in first months; rest and nutrition help.\n\nArthralgia/Myalgia (14-21%): Joint/muscle pain managed with NSAIDs.\n\nHot Flashes (20%): Androgen blockade mimic; hydration aids.\n\nHeadache/Dizziness (12-19%): Transient; avoid driving if severe.\n\nHypertension (6-13%): Monitor BP monthly; antihypertensives as needed.\n\nGI Issues (diarrhea 12%, nausea 11%): Antiemetics support compliance.​\n\nSerious Side Effects\nSeizures (0.9%): Highest risk in epileptics or brain mets; EEG baseline, avoid triggers.\n\nPosterior Reversible Encephalopathy (PRES): Rare (<0.1%); headache, confusion—MRI confirms.\n\nFalls/Fractures (15% increased risk): Due to weakness/falls; DEXA scans recommended.\n\nCardiac Events (2-5%): MI/arrhythmias; ECG monitoring in CVD history.\n\nHepatic Injury (1%): ALT/AST elevation; monthly labs first 3 months.​\n\nDiscontinuation occurs in 8-10%; supportive care mitigates most.​\n\nDosage and Administration\nStandard dose: 160 mg (four 40 mg capsules) once daily, with or without food. Swallow intact; no crushing. Adjust for CYP2A4 inducers (e.g., rifampin—increase to 240 mg) or strong inhibitors (reduce to 80 mg). Continue until progression/toxicity; no dose interruptions beyond 28 days without reassessment.​\n\nPrecautions and Monitoring\nContraindicated in pregnancy (teratogenic; absolute contraception for men/ partners). Screen for seizure history; CYP2C8/3A4 interactions (e.g., ketoconazole). Baseline LFTs, PSA, testosterone; imaging q8-12 weeks. Elderly (>75) monitor falls.​\nConclusion\nEnzalutamide 40 mg stands as a transformative therapy, empowering prostate cancer patients with prolonged control over aggressive disease through precise AR inhibition. Balancing robust efficacy—evidenced by landmark trials delaying metastasis and death—with proactive side effect management, it enhances survival and daily living. Patients achieve meaningful milestones, from family events to travel, underscoring its role in personalized oncology. Consult oncologists for integration into care plans, ensuring optimal outcomes in this challenging journey.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n\n", "price": 10781.0, "discountamount": 3235.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "doctor", "product", "fatigue", "WhatsApp", "treatment", "schedules", "ENZULAMIDE", "monitoring", "hot flashes", "information", "sterisonline", "hypertension", "sterispharma", "prostate cancer", "Enzalutamide 40mg", "prescribed dosages", "androgen receptors", "cancer cell growth", "Common side effects", "comprehensive guidance" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1527, "imageuri": "https://productimages.withfloats.com/actual/667d2a356c582d228f45a098.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2a356c582d228f45a098.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:40:56.587Z", "updatedon": "2026-03-16T08:18:18.117Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//enzalutamide-40mg/1527", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 40", "category": "Oncology", "tags": [ "enzalutamide 40 mg side effects", "enzalutamide 40 mg brands in india", "enzalutamide 40 mg uses in hindi", "enzalutamide 40 mg dosage", "advanced prostate cancer", "prostate cancer", "metastatic castration-resistant prostate cancer", "enzalutamide 40mg tablets", "enzalutamide 40 mg capsule", "enzalutamide 40mg uses", "enzalutamide 40mg dosage", "enzalutamide 40mg price in india", "enzalutamide 40mg composition", "enzalutamide 40mg working mechanism", "enzalutamide 40mg side effects", "enzalutamide 40mg benefits", "enzalutamide 40mg drug information", "enzalutamide 40mg therapy details", "enzalutamide 40mg oral capsule", "enzalutamide 40mg treatment option", "enzalutamide 40mg pharmaceutical uses", "enzalutamide 40mg branded tablets", "enzalutamide 40mg generic medicine", "enzalutamide 40mg manufacturer in india", "what is enzalutamide 40mg used for", "how enzalutamide 40mg works", "is enzalutamide 40mg safe", "enzalutamide 40mg tablet information", "enzalutamide 40mg dosage guidelines" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662ca65a743fd235822236b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "abiraterone acetate 250mg", "description": "ABIRASTERON 250\nAbiraterone Acetate 250mg\nProstate cancer is one of the most commonly diagnosed cancers in men, especially in older age. As the disease progresses, it often becomes dependent on male hormones—particularly testosterone—for growth and spread. Modern cancer treatment focuses on cutting off this hormonal fuel to slow disease progression and improve survival.\n\nABIRASTERON 250, containing abiraterone acetate 250 mg, is a proven oral anti-cancer medicine used in the treatment of advanced prostate cancer. It works by blocking the production of androgens (male hormones) not only in the testes but also in the adrenal glands and within the tumor itself. This comprehensive hormonal suppression makes ABIRASTERON 250 an important therapy in long-term prostate cancer care.\n\nComposition of ABIRASTERON 250\n\nEach tablet of ABIRASTERON 250 contains:\n\nAbiraterone Acetate – 250 mg\n\nExcipients q.s.\n\nAbiraterone acetate belongs to the class of medicines known as androgen biosynthesis inhibitors.\n\nHow ABIRASTERON 250 Works (Mechanism of Action)\n\nTo understand the importance of abiraterone acetate, it helps to know how prostate cancer grows.\n\nProstate cancer cells rely heavily on androgens (testosterone and related hormones) for survival and multiplication. Even when testicular testosterone production is suppressed (through surgery or hormone injections), the body continues to produce small amounts of androgens from the adrenal glands and the tumor itself.\n\nMechanism of Action of Abiraterone Acetate\n\nABIRASTERON 250 works by:\n\nInhibiting the enzyme CYP17 (17α-hydroxylase/C17,20-lyase)\n\nBlocking androgen production in:\n\nTestes\n\nAdrenal glands\n\nProstate cancer cells\n\nReducing circulating testosterone levels to extremely low levels\n\nBy depriving cancer cells of hormones, ABIRASTERON 250 slows tumor growth, delays disease progression, and improves clinical outcomes.\n\nBecause abiraterone also reduces cortisol production, it is usually prescribed along with low-dose corticosteroids (such as prednisone) to maintain hormonal balance.\n\nUses of ABIRASTERON 250\n\nABIRASTERON 250 is indicated for the treatment of:\n\n1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)\n\nProstate cancer that has spread to other parts of the body\n\nDisease progression despite testosterone-lowering therapy\n\n2. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)\n\nAdvanced prostate cancer that still responds to hormonal therapy\n\nUsed in combination with androgen deprivation therapy (ADT)\n\n3. Advanced Prostate Cancer\n\nIn patients where long-term disease control is required\n\nOften used before or after chemotherapy, depending on clinical condition\n\nABIRASTERON 250 has become a standard of care in many prostate cancer treatment protocols worldwide.\n\nWho Should Use ABIRASTERON 250?\n\nABIRASTERON 250 is prescribed for:\n\nAdult male patients with advanced prostate cancer\n\nPatients whose disease is driven by androgen hormones\n\nIndividuals under oncologist supervision\n\nPatients requiring oral, long-term hormonal therapy\n\nIt should always be taken only under medical guidance.\n\nHow to Take ABIRASTERON 250\n\nCorrect administration is crucial for safety and effectiveness.\n\nDosage and Administration\n\nUsually taken once daily as prescribed\n\nMust be taken on an empty stomach\n\nAt least 1 hour before or 2 hours after food\n\nSwallow tablets whole with water\n\nTaken along with prescribed corticosteroid\n\nTaking abiraterone with food can increase drug absorption excessively and raise the risk of side effects, so fasting intake is essential.\n\nKey Benefits of ABIRASTERON 250\n1. Effective Hormonal Suppression\n\nBlocks androgen production from all major sources, not just the testes.\n\n2. Slows Cancer Progression\n\nHelps delay tumor growth and spread in advanced prostate cancer.\n\n3. Improves Survival Outcomes\n\nClinical studies have shown improved overall survival and progression-free survival.\n\n4. Oral Therapy Convenience\n\nTablet form allows treatment at home without frequent hospital visits.\n\n5. Delays Need for Chemotherapy\n\nIn many patients, abiraterone postpones or reduces reliance on chemotherapy.\n\n6. Improves Quality of Life\n\nBetter symptom control, reduced bone pain, and improved daily functioning in many patients.\n\nSide Effects of ABIRASTERON 250\n\nLike all anti-cancer medicines, ABIRASTERON 250 may cause side effects. Most are manageable with monitoring and supportive care.\n\nCommon Side Effects\n\nFatigue\n\nJoint or muscle pain\n\nSwelling of legs or ankles (fluid retention)\n\nHot flashes\n\nHigh blood pressure\n\nLow potassium levels\n\nIncreased liver enzymes\n\nLess Common Side Effects\n\nHeadache\n\nUrinary tract infections\n\nIrregular heartbeat\n\nDigestive discomfort\n\nChanges in cholesterol levels\n\nSerious Side Effects (Require Medical Attention)\n\nSevere liver dysfunction\n\nMarked electrolyte imbalance\n\nHeart rhythm disturbances\n\nSevere swelling or shortness of breath\n\nSigns of adrenal insufficiency\n\nRegular blood tests help detect these issues early.\n\nPrecautions and Warnings\n\nNot for use in women or children\n\nUse with caution in patients with liver disease\n\nBlood pressure and potassium levels should be monitored\n\nLiver function tests are required regularly\n\nMust not be stopped or adjusted without doctor consultation\n\nEffective contraception is advised if there is any chance of exposure during handling\n\nDrug Interactions\n\nABIRASTERON 250 may interact with:\n\nCertain blood pressure medicines\n\nHeart rhythm medications\n\nDrugs metabolized by liver enzymes\n\nAlways inform your doctor about all medicines you are taking.\n\nWhy ABIRASTERON 250 Is an Important Treatment Option\n\nWhat makes ABIRASTERON 250 particularly valuable is its ability to target hormone production at multiple levels, offering deeper androgen suppression than traditional therapies alone. It represents a shift toward more precise, targeted prostate cancer management, improving outcomes while maintaining quality of life.\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and heat\n\nKeep out of reach of children\n\nHandle tablets with care\n\nConclusion\n\nABIRASTERON 250 (Abiraterone Acetate 250 mg) is a powerful and well-established therapy for advanced and metastatic prostate cancer. By effectively blocking androgen production throughout the body, it slows disease progression, improves survival, and helps patients maintain a better quality of life. When taken correctly under medical supervision and with appropriate monitoring, ABIRASTERON 250 plays a vital role in modern prostate cancer treatment strategies.\n", "price": 39000.0, "discountamount": 23399.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "250mg", "Order", "Email", "mCRPC", "testes", "growth", "doctor", "nausea", "dosage", "fatigue", "unusual", "diarrhea", "response", "guidance", "duration", "strength", "WhatsApp", "androgens", "treatment", "joint pain", "prednisone", "hot flashes", "combination", "information", "supervision", "ABIRASTERON", "testosterone", "sterispharma", "prednisolone", "sterisonline", "crucial role", "enzyme CYP17A", "empty stomach", "adrenal glands", "prostate gland", "fluid retention", "hormone therapy", "potent inhibitor", "medical condition", "other medications", "high blood pressure", "Common side effects", "severe side effects", "therapeutic effects", "androgen production", "healthcare provider", "prostate cancer cells", "prostate tumor tissue", "androgen biosynthesis", "Abiraterone Acetate LP", "prescription medication", "healthcare professional", "gastrointestinal disturbances", "metastatic castration-resistant prostate cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1516, "imageuri": "https://productimages.withfloats.com/actual/667d334f6c582d228f45a9d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d334f6c582d228f45a9d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:52:53.718Z", "updatedon": "2026-03-14T12:21:19.014Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//abiraterone-acetate-250mg/1516", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ABIRASTERON 250", "category": "GENERAL RANGE", "tags": [ "abiraterone acetate 250 mg brands in india", "abiraterone acetate 250 mg brands in india", "abiraterone acetate side effects", "abiraterone acetate 250 mg tablets", "abiraterone acetate 250mg uses", "abiraterone acetate tablet 250 mg", "abiraterone acetate 250 mg medicine", "abiraterone acetate 250mg dosage", "abiraterone acetate 250 mg price", "what is abiraterone acetate 250 mg used for", "how abiraterone acetate works in prostate cancer", "abiraterone acetate mechanism of action", "abiraterone acetate 250 mg treatment purpose", "abiraterone acetate 250 mg price in india", "buy abiraterone acetate 250 mg online", "abiraterone acetate 250 mg tablets cost", "abiraterone acetate 250 mg supplier india", "abiraterone acetate 250 mg wholesale" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662b9b3ce0b5041cf8896b70", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "abiraterone acetate 250 mg", "description": "ABIRASTERON 250 \nAbiraterone Acetate lp (250mg) \nCancer treatment has advanced significantly over the years, with targeted therapies offering improved outcomes and better quality of life for patients. Among these, hormone-based therapies have proven highly effective in managing certain types of cancers. One such important treatment is Abiraterone Acetate, widely used in the management of prostate cancer.\n\nABIRASTERON 250 is a high-quality formulation containing Abiraterone Acetate 250 mg, designed to help control the progression of prostate cancer by targeting androgen production. This medication is particularly beneficial for patients with advanced or metastatic prostate cancer, where controlling hormone levels plays a crucial role in slowing disease progression.\n\nComposition\n\nAbiraterone Acetate 250 mg\n\nThis active ingredient is a potent androgen biosynthesis inhibitor that helps reduce the levels of male hormones responsible for cancer growth.\n\nHow ABIRASTERON 250 Works\n\nAbiraterone Acetate works by targeting a specific enzyme known as CYP17 (17α-hydroxylase/C17,20-lyase), which is essential in the production of androgens (male hormones such as testosterone).\n\nMechanism of Action\n\nBlocks androgen production in the testes, adrenal glands, and tumor tissues\n\nReduces testosterone levels significantly\n\nSlows down or stops the growth of prostate cancer cells\n\nEnhances the effectiveness of other cancer treatments\n\nUnlike traditional therapies that only reduce testosterone from the testes, Abiraterone works throughout the body, making it more comprehensive in action.\n\nUses of ABIRASTERON 250\n1. Metastatic Castration-Resistant Prostate Cancer (mCRPC)\n\nUsed in patients whose cancer continues to progress despite low testosterone levels\n\nHelps slow disease progression and improve survival rates\n\n2. Metastatic High-Risk Castration-Sensitive Prostate Cancer (mCSPC)\n\nUsed in combination with other therapies for newly diagnosed advanced cases\n\n3. Hormone-Sensitive Prostate Cancer\n\nHelps control cancer growth by reducing androgen levels\n\n4. Combination Therapy\n\nOften prescribed along with corticosteroids (such as prednisone) to enhance effectiveness and manage side effects\n\nKey Benefits of ABIRASTERON 250\n1. Targeted Cancer Therapy\n\nSpecifically inhibits androgen production, directly targeting cancer growth pathways\n\n2. Improves Survival Outcomes\n\nProven to extend survival in patients with advanced prostate cancer\n\n3. Slows Disease Progression\n\nHelps delay the spread of cancer to other parts of the body\n\n4. Reduces Tumor Activity\n\nDecreases prostate-specific antigen (PSA) levels, indicating reduced tumor activity\n\n5. Enhances Quality of Life\n\nHelps reduce cancer-related symptoms such as bone pain and fatigue\n\n6. Works Beyond Traditional Hormone Therapy\n\nEffective even when standard hormone treatments fail\n\n7. Convenient Oral Administration\n\nTablet form allows easy and non-invasive treatment compared to injectable therapies\n\nDosage and Administration\n\nTake ABIRASTERON 250 exactly as prescribed by your oncologist\n\nUsually taken once daily on an empty stomach (at least 1 hour before or 2 hours after food)\n\nSwallow tablets whole with water\n\nTypically used in combination with a corticosteroid (e.g., prednisone)\n\nDo not skip doses or discontinue without medical advice\n\nSide Effects of ABIRASTERON 250\n\nLike all cancer medications, ABIRASTERON 250 may cause side effects. Monitoring is essential during treatment.\n\nCommon Side Effects\n\nFatigue\n\nJoint pain or swelling\n\nHigh blood pressure\n\nFluid retention (edema)\n\nHot flashes\n\nLess Common Side Effects\n\nLow potassium levels (hypokalemia)\n\nLiver enzyme elevation\n\nMuscle weakness\n\nDiarrhea\n\nSerious Side Effects (Require Immediate Attention)\n\nSevere liver problems (yellowing of skin/eyes, dark urine)\n\nSevere hypertension\n\nHeart rhythm disorders\n\nAdrenal insufficiency\n\nSevere allergic reactions\n\nRegular blood tests are usually required to monitor liver function, potassium levels, and overall health.\n\nPrecautions and Warnings\n\nLiver Disease: Use with caution; regular monitoring is essential\n\nHeart Conditions: May increase risk of cardiovascular issues\n\nElectrolyte Imbalance: Monitor potassium levels regularly\n\nPregnancy and Women: Not intended for use in women, especially during pregnancy\n\nDrug Interactions: Inform your doctor about all medications being taken\n\nFood Interaction: Must be taken on an empty stomach to avoid increased drug absorption\n\nWho Should Use ABIRASTERON 250?\n\nThis medication is suitable for:\n\nPatients with advanced or metastatic prostate cancer\n\nIndividuals not responding to conventional hormone therapy\n\nPatients requiring long-term androgen suppression therapy\n\nLifestyle and Supportive Care\n\nWhile taking ABIRASTERON 250:\n\nMaintain a balanced diet rich in nutrients\n\nMonitor blood pressure regularly\n\nStay physically active as per doctor’s advice\n\nAttend regular follow-up appointments\n\nAvoid alcohol or substances that may affect liver function\n\nConclusion\n\nABIRASTERON 250 (Abiraterone Acetate 250 mg Tablets) is a highly effective, targeted therapy for the management of advanced prostate cancer. By inhibiting androgen production at multiple levels in the body, it plays a crucial role in slowing cancer progression and improving patient survival.", "price": 39000.0, "discountamount": 23400.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "symptoms", "hormones", "patients", "androgens", "treatment", "combination", "ABIRASTERON", "250mg strength", "other therapies", "overall quality", "optimal outcomes", "vital medication", "cancer progression", "androgen production", "innovative formulation", "Abiraterone Acetate lp", "prostate cancer growth", "advanced prostate cancer", "close medical supervision" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 767, "imageuri": "https://productimages.withfloats.com/actual/69301b5be93be7406683e3fe.png", "tileimageuri": "https://productimages.withfloats.com/tile/69301b5be93be7406683e3fe.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:17:00.614Z", "updatedon": "2026-03-20T09:59:33.46Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//abiraterone-acetate-250-mg/767", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ABIRASTERON 250", "category": "Oncology", "tags": [ "Abiraterone Acetate lp at 250mg", "prostate cancer growth", "androgen production", "managing advanced prostate cancer", "abiraterone acetate 250 mg tablets uses", "abiraterone acetate 250 mg how it works", "abiraterone acetate 250 mg benefits in prostate cancer", "abiraterone acetate 250 mg side effects long term", "abiraterone acetate 250 mg tablets india", "abiraterone acetate 250 mg tablets for advanced prostate cancer", "best treatment for prostate cancer abiraterone acetate", "abiraterone acetate 250 mg for metastatic prostate cancer", "hormone therapy for prostate cancer tablets india", "what is abiraterone acetate 250 mg used for", "how to take abiraterone acetate 250 mg tablets", "abiraterone acetate 250 mg side effects in hindi", "buy abiraterone acetate 250 mg tablets online", "abiraterone acetate 250 mg price in india", "best price abiraterone acetate 250 mg tablets", "biraterone acetate 250 mg pharma franchise", "abiraterone acetate 250 mg benefits in hindi", "abiraterone acetate 250 mg survival rate prostate cancer" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "69e0b33ed924338730097867", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "aspirin gastro resistant and rosuvastatin capsules ip uses", "description": "Introduction\n\nROUSTRIN AV 5 is a combination medication formulated to support heart health and reduce the risk of cardiovascular diseases. It contains two clinically proven ingredients: Aspirin 75 mg (gastro-resistant) and Rosuvastatin 5 mg. This dual-action capsule is widely prescribed for patients who are at risk of heart attack, stroke, or other cardiovascular complications.\n\nAspirin works as an antiplatelet agent, preventing blood clot formation, while Rosuvastatin belongs to the statin class of drugs that help lower cholesterol levels in the body. Together, they provide comprehensive protection by addressing both clot formation and lipid imbalance—two major causes of heart-related disorders.\n\nROUSTRIN AV 5 is especially beneficial for individuals with a history of heart disease, high cholesterol, hypertension, or diabetes. The gastro-resistant formulation ensures that Aspirin is released in the intestine rather than the stomach, reducing the risk of gastric irritation.\n\nUses of ROUSTRIN AV 5\n\nROUSTRIN AV 5 is commonly prescribed for the prevention and management of cardiovascular conditions. Its primary uses include:\n\nPrevention of heart attack (myocardial infarction)\nReduction in the risk of stroke\nManagement of high cholesterol (hyperlipidemia)\nPrevention of blood clot formation in arteries\nTreatment support for patients with coronary artery disease\nSecondary prevention in patients with previous cardiovascular events\n\nThis medication is often recommended as part of long-term therapy for maintaining heart health and preventing life-threatening complications.\n\nHow ROUSTRIN AV 5 Works\nAspirin 75 mg (Gastro-Resistant)\n\nAspirin inhibits platelet aggregation by blocking the production of thromboxane A2, a chemical responsible for blood clot formation. The gastro-resistant coating protects the stomach lining, ensuring safer long-term use.\n\nRosuvastatin 5 mg\n\nRosuvastatin reduces “bad cholesterol” (LDL) and triglycerides while increasing “good cholesterol” (HDL). It works by inhibiting the HMG-CoA reductase enzyme in the liver, which is responsible for cholesterol synthesis.\n\nTogether, these components reduce plaque formation in arteries and improve blood flow, significantly lowering the risk of cardiovascular events.\n\nKey Benefits of ROUSTRIN AV 5\n1. Dual Protection for Heart Health\n\nCombines antiplatelet and cholesterol-lowering actions, offering comprehensive cardiovascular protection.\n\n2. Reduces Risk of Heart Attack and Stroke\n\nHelps prevent clot formation and arterial blockage, which are major causes of heart attacks and strokes.\n\n3. Effective Cholesterol Management\n\nLowers LDL cholesterol and improves lipid profile, reducing long-term cardiovascular risk.\n\n4. Gastro-Resistant Formula\n\nMinimizes stomach irritation and enhances patient compliance during long-term use.\n\n5. Suitable for High-Risk Patients\n\nIdeal for patients with diabetes, hypertension, obesity, or family history of heart disease.\n\n6. Improves Blood Circulation\n\nPrevents clot formation and maintains smooth blood flow throughout the body.\n\nDosage and Administration\n\nROUSTRIN AV 5 should be taken strictly as prescribed by a healthcare professional.\n\nUsually taken once daily\nSwallow the capsule whole with water\nDo not crush or chew the capsule\nPreferably taken at the same time each day for best results\nCan be taken with or without food\n\nIt is important to follow the prescribed dosage and not discontinue the medication without consulting your doctor, even if you feel well.\n\nSide Effects of ROUSTRIN AV 5\n\nLike all medications, ROUSTRIN AV 5 may cause some side effects. Most are mild and temporary, but some may require medical attention.\n\nCommon Side Effects\nHeadache\nNausea or vomiting\nStomach discomfort\nMuscle pain\nWeakness\nLess Common Side Effects\nIndigestion\nDizziness\nConstipation\nIncreased liver enzymes\nSerious Side Effects (Seek Immediate Medical Help)\nUnusual bleeding or bruising\nSevere stomach pain or ulcers\nAllergic reactions (rash, swelling, difficulty breathing)\nSevere muscle pain (possible muscle breakdown)\nDark-colored urine or jaundice\n\nIf any unusual symptoms occur, it is important to consult a healthcare provider promptly.\n\nPrecautions and Warnings\n\nBefore using ROUSTRIN AV 5, consider the following precautions:\n\n1. Medical History\n\nInform your doctor if you have:\n\nLiver or kidney disease\nHistory of stomach ulcers or bleeding\nAsthma or allergy to Aspirin\nMuscle disorders\n2. Pregnancy and Breastfeeding\nNot recommended during pregnancy unless prescribed\nConsult a doctor before use during breastfeeding\n3. Alcohol Consumption\n\nAvoid excessive alcohol intake as it may increase the risk of liver damage and stomach bleeding.\n\n4. Drug Interactions\n\nROUSTRIN AV 5 may interact with:\n\nBlood thinners (warfarin, heparin)\nOther NSAIDs\nCertain antibiotics\nAntifungal medications\n\nAlways inform your doctor about all medications and supplements you are taking.\n\n5. Regular Monitoring\n\nPatients may require periodic monitoring of:\n\nLiver function\nLipid profile\nKidney function\nStorage Instructions\nStore in a cool, dry place\nKeep away from direct sunlight\nKeep out of reach of children\nDo not use after the expiry date\nConclusion\n\nROUSTRIN AV 5 (Aspirin 75 mg Gastro-Resistant & Rosuvastatin 5 mg Capsules) is a highly effective combination therapy designed to protect heart health and prevent serious cardiovascular conditions. By combining the blood-thinning action of Aspirin with the cholesterol-lowering effect of Rosuvastatin, it provides a comprehensive solution for individuals at risk of heart disease.", "price": 125.0, "discountamount": 37.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2381, "imageuri": "https://productimages.withfloats.com/actual/69e0b3da7207f3415693ca4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e0b3da7207f3415693ca4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-16T10:00:30.807Z", "updatedon": "2026-04-17T09:44:14.825Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//aspirin-gastro-resistant-and-rosuvastatin-capsules-ip-uses/2381", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROUSTRIN AV 5", "category": "CARDIOLOGYRANGE", "tags": [ "rosuvastatin 5 mg", "rosuvastatin 5 mg uses", "rosuvastatin 5 mg uses in hindi", "rosuvastatin 5 mg price", "rosuvastatin 5 mg price in india", "is rosuvastatin 5 mg safe to take", "aspirin 75 mg", "aspirin 75 mg uses", "aspirin 75 mg price", "aspirin 75 mg uses", "aspirin gastro resistant and rosuvastatin capsules ip uses", "aspirin gastro resistant and rosuvastatin capsules", "aspirin gastro resistant and rosuvastatin capsules uses", "aspirin gastro resistant and rosuvastatin", "aspirin gastro resistant and rosuvastatin capsule" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69d8e821f75e521c210f0942", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nilotinib 150mg", "description": "NILOTHERAPY 150 is a prescription medication containing Nilotinib 150 mg, a targeted therapy primarily used in the treatment of certain types of blood cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins responsible for cancer cell growth. This medication is widely prescribed for patients diagnosed with Chronic Myeloid Leukemia (CML), especially those who are resistant or intolerant to other treatments.\n\nNILOTHERAPY 150 is designed to provide effective disease control while improving long-term outcomes and quality of life for patients.\n\nWhat is Nilotinib 150 mg?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, an abnormal protein produced in patients with Chronic Myeloid Leukemia. By inhibiting this protein, NILOTHERAPY 150 helps slow down or stop the uncontrolled growth of cancer cells.\n\nUnlike traditional chemotherapy, Nilotinib is a targeted therapy, meaning it focuses on cancer cells with minimal damage to healthy cells, making it a more precise and often better-tolerated treatment option.\n\nUses of NILOTHERAPY 150\n\nNILOTHERAPY 150 is primarily prescribed for:\n\n1. Chronic Myeloid Leukemia (CML)\nUsed in adults and children diagnosed with Philadelphia chromosome-positive CML.\nEffective in both newly diagnosed patients and those who cannot tolerate other treatments like Imatinib.\n2. Resistant or Intolerant CML Cases\nHelps patients who have not responded adequately to first-line therapies.\nOffers an alternative with improved efficacy in certain resistant mutations.\n3. Long-Term Disease Management\nHelps maintain remission and prevent disease progression to advanced stages such as accelerated or blast phase CML.\nKey Benefits of NILOTHERAPY 150\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 150 directly targets cancer-causing proteins, minimizing damage to healthy cells and reducing many of the harsh side effects associated with chemotherapy.\n\n2. High Effectiveness\n\nClinical studies have shown that Nilotinib can achieve faster and deeper molecular responses compared to older treatments.\n\n3. Improved Survival Rates\n\nPatients using Nilotinib often experience better long-term survival outcomes when taken as prescribed.\n\n4. Oral Administration\n\nUnlike intravenous cancer treatments, NILOTHERAPY 150 is taken orally, making it convenient and easier to incorporate into daily life.\n\n5. Reduced Disease Progression\n\nHelps prevent the progression of CML into more aggressive stages, offering better disease control.\n\n6. Suitable for Resistant Cases\n\nEffective for patients who do not respond well to first-generation TKIs, providing a second chance at disease management.\n\nHow NILOTHERAPY 150 Works\n\nNilotinib works by blocking the activity of the BCR-ABL tyrosine kinase enzyme. This enzyme sends signals that tell cancer cells to grow and divide uncontrollably. By inhibiting this signal, NILOTHERAPY 150:\n\nStops cancer cell multiplication\nInduces cancer cell death\nHelps restore normal blood cell production\nDosage and Administration\nTypically taken twice daily on an empty stomach (at least 2 hours after a meal and 1 hour before the next meal).\nSwallow capsules whole with water.\nAlways follow your doctor’s prescribed dosage and schedule.\n\n⚠️ Do not adjust the dose without medical advice.\n\nPossible Side Effects of NILOTHERAPY 150\n\nLike all medications, NILOTHERAPY 150 may cause side effects. While not everyone experiences them, it’s important to be aware:\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nSkin rash\nConstipation or diarrhea\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nIncreased blood sugar levels\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nChest pain or irregular heartbeat\nSevere abdominal pain\nUnusual bleeding or bruising\nYellowing of skin or eyes\nPrecautions and Warnings\nInform your doctor if you have a history of heart disease, liver problems, or electrolyte imbalances.\nAvoid grapefruit and grapefruit juice as they may interfere with the drug’s effectiveness.\nRegular blood tests and monitoring are essential during treatment.\nNot recommended during pregnancy or breastfeeding unless advised by a healthcare professional.\nDrug Interactions\n\nNILOTHERAPY 150 may interact with other medications, including:\n\nAntifungal drugs\nAntibiotics\nHeart medications\nCertain antidepressants\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place below 25°C\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nNILOTHERAPY 150 (Nilotinib 150 mg) is a highly effective, targeted treatment for Chronic Myeloid Leukemia, offering patients a modern alternative to traditional chemotherapy. Its ability to specifically inhibit cancer-causing proteins makes it a powerful tool in controlling disease progression and improving long-term survival.", "price": 3270.0, "discountamount": 981.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2375, "imageuri": "https://productimages.withfloats.com/actual/69d8e8255352fce06529f51e.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8e8255352fce06529f51e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T12:08:01.629Z", "updatedon": "2026-04-14T12:51:27.608Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nilotinib-150mg/2375", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NILOTHERAPY 150", "category": "Oncology", "tags": [ "nilotinib 150mg", "nilotinib 150mg capsule", "nilotinib side effects", "nilotinib 150 mg price", "nilotinib 150 mg", "nilotinib 150 mg price", "nilotinib 150mg availability in india", "buy nilotinib 150mg online india prescription", "nilotinib 150mg side effects long term use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69d8d9f47c7c4d696c414270", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nilotinib 200mg", "description": "NILOTHERAPY 200 is a targeted anti-cancer medication containing Nilotinib 200 mg, primarily used in the treatment of chronic myeloid leukemia (CML). It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking the abnormal proteins responsible for cancer cell growth.\n\nDeveloped to provide more precise and effective cancer treatment, NILOTHERAPY 200 offers improved outcomes compared to traditional therapies. It is commonly prescribed for patients who are newly diagnosed with CML or those who have not responded well to other treatments.\n\nWhat is Nilotinib and How Does It Work?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, a key driver of leukemia cell growth.\n\nMechanism of Action\nBlocks abnormal signals that promote cancer cell multiplication\nStops the growth and spread of leukemia cells\nHelps restore normal blood cell production\n\nUnlike chemotherapy, which affects both healthy and cancerous cells, Nilotinib works in a targeted manner, reducing damage to normal cells and improving treatment tolerability.\n\nUses of NILOTHERAPY 200\n1. Treatment of Chronic Myeloid Leukemia (CML)\n\nNILOTHERAPY 200 is widely used for:\n\nNewly diagnosed Philadelphia chromosome-positive CML\nChronic phase and accelerated phase CML\nPatients resistant or intolerant to prior therapies\n2. Long-Term Disease Control\n\nIt helps maintain remission and prevents disease progression when taken regularly as prescribed.\n\n3. Alternative to First-Line Therapies\n\nFor patients who do not respond well to other medications, NILOTHERAPY 200 serves as an effective alternative.\n\nKey Benefits of NILOTHERAPY 200\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 200 specifically attacks cancer cells without extensively harming healthy cells, making it more precise than conventional chemotherapy.\n\n2. High Effectiveness in CML Management\n\nClinical studies have shown that Nilotinib provides:\n\nFaster molecular response\nImproved long-term survival rates\nReduced risk of disease progression\n3. Oral Convenience\n\nThe capsule form allows patients to take the medication at home, avoiding frequent hospital visits.\n\n4. Improved Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional treatments, enabling better daily functioning.\n\n5. Suitable for Resistant Cases\n\nEffective in patients who have developed resistance to earlier therapies like imatinib.\n\nDosage and Administration\nTypically taken twice daily, approximately 12 hours apart\nMust be taken on an empty stomach (avoid food 2 hours before and 1 hour after)\nSwallow capsules whole with water\nFollow your doctor’s exact dosage instructions\nImportant Tip\n\nDo not skip doses or stop treatment without medical advice, as this may affect treatment outcomes.\n\nPossible Side Effects of NILOTHERAPY 200\n\nLike all medications, NILOTHERAPY 200 may cause side effects. While many are manageable, some require immediate attention.\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nConstipation or diarrhea\nMuscle or joint pain\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nSudden weight gain or swelling\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nIrregular heartbeat\nSevere abdominal pain\nYellowing of skin or eyes\nUnusual bleeding or bruising\nPrecautions and Warnings\n\nBefore starting NILOTHERAPY 200, consider the following:\n\nInform your doctor if you have heart disease, liver problems, or electrolyte imbalance\nRegular ECG monitoring may be required\nAvoid grapefruit and grapefruit juice during treatment\nNot recommended during pregnancy unless prescribed\nUse effective contraception during treatment\nDrug Interactions\n\nNilotinib may interact with:\n\nAntifungal medications\nAntibiotics\nHeart rhythm drugs\nAntacids\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore below 30°C in a dry place\nKeep away from moisture and direct sunlight\nKeep out of reach of children\nWhy Choose NILOTHERAPY 200?\n\nNilotherapy 200 stands out due to the following:\n\nAdvanced targeted therapy mechanism\nProven success in treating CML\nConvenient oral dosage\nEffective in resistant and intolerant cases\nTrusted pharmaceutical quality\nConclusion\n\nNILOTHERAPY 200 (Nilotinib 200 mg Capsules) is a powerful and reliable treatment option for patients with chronic myeloid leukemia. Its targeted mechanism, high effectiveness, and convenient oral administration make it a preferred choice among healthcare professionals.", "price": 3570.0, "discountamount": 1071.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2374, "imageuri": "https://productimages.withfloats.com/actual/69d8d9fb0f2d50aed157389c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8d9fb0f2d50aed157389c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T11:07:32.379Z", "updatedon": "2026-05-26T06:50:48.256Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nilotinib-200mg/2374", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NILOTHERAPY 200", "category": "Oncology", "tags": [ "nilotinib 200mg", "nilotinib 200mg price", "tab nilotinib 200mg", "nilotinib 200mg price in india", "nilotinib 200mg in hindi", "nilotinib 200mg tab", "nilotinib 200mg side effects", "nilotinib 200mg brands in india", "nilotinib 200mg uses", "nilotinib 200mg price online", "nilotinib 200mg generic vs branded price comparison0", "is nilotinib 200mg available without prescription India", "nilotinib 200mg lead time suppliers India", "nilotinib 200mg vs imatinib price India", "nilotinib 200mg exporters from India", "nilotinib 200mg global suppliers GMP WHO certified", "nilotinib 200mg hospital procurement price India", "Buy Nilotinib 200mg Capsules Online", "Nilotinib 200mg Anti Cancer Medicine", "Nilotinib 200mg Prescription Medicine", "Nilotinib 200mg Product Image", "Best Leukemia Treatment Medicine Nilotinib", "Nilotinib Capsules for Blood Cancer Treatment", "Nilotinib 200mg Oncology Medicine", "Targeted Cancer Therapy Capsules", "Nilotinib 200mg Chemotherapy Support Medicine" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69316145bf2a5ce08905eadf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Temozolomide 250 mg", "description": "Temozolomide 250 mg, marketed under the brand name TMOZOLMIDE 250 by Steris Healthcare, is a potent chemotherapy drug primarily used to treat certain aggressive brain tumors such as glioblastoma multiforme (GBM) and anaplastic astrocytoma. Its mechanism of action involves alkylation of DNA, which damages the cancer cells’ DNA strands, leading to their programmed death and inhibition of tumor growth. This effect is achieved through the addition of a methyl group at the O6 and N7 positions of guanine in DNA. Tumor cells damaged by this process are unable to reproduce and eventually die, making Temozolomide an effective agent in chemotherapy regimens[,].​\n\nWhat are the benefits of temozolomide 250 mg?\nTemozolomide 250 mg offers significant benefits for patients battling brain cancers. It crosses the blood-brain barrier effectively, which allows it to reach tumor cells inside the brain where many other drugs cannot penetrate. This expands its efficacy in treating primary brain tumors and certain metastatic tumors that have spread to the brain. In clinical settings, it has been shown to improve progression-free survival rates and, in some cases, overall survival when used with radiation therapy or alone during maintenance treatment phases[,].​\n\nKey Benefits of Temozolomide 250 mg\nEffective treatment of aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma.\n\nCan be administered orally, offering convenience compared to intravenous chemotherapy.\n\nAbility to cross the blood-brain barrier, ensuring targeted therapy within the central nervous system.\n\nWell-established as part of the standard Stupp protocol (combined with radiotherapy).\n\nMay improve quality of life by slowing tumor progression and managing symptoms associated with brain tumors[,].​\n\nSide Effects of Temozolomide 250 mg\nWhile Temozolomide is effective, it may cause side effects common to chemotherapy medications due to its impact on both cancerous and healthy rapidly dividing cells.\n\nCommon Side Effects of Temozolomide 250 mg\nNausea and vomiting, which can sometimes be severe.\n\nFatigue and weakness.\n\nHair thinning or hair loss.\n\nConstipation or diarrhea.\n\nLoss of appetite.\n\nMouth sores or changes in taste.\n\nDizziness or headache.\n\nMild skin rashes or itching[,].​\n\nSerious Side Effects of Temozolomide 250 mg\nSignificant reduction in blood cell counts causing anemia, leukopenia, or thrombocytopenia (requiring close blood monitoring).\n\nSevere infections due to immune suppression.\n\nAllergic reactions, including swelling, itching, or rash.\n\nLiver dysfunction or jaundice.\n\nSeizures or neurological symptoms.\n\nUnusual bleeding or bruising.\n\nSigns of severe allergic reaction like difficulty breathing[,].​\n\nAvailable Substitute for Temozolomide 250 mg\nThere are limited direct substitutes for Temozolomide due to its unique ability to treat brain tumors crossing the blood-brain barrier. Alternatives depend on tumor type and may include other chemotherapy drugs like lomustine (CCNU), carmustine (BCNU), or newer targeted therapies and immunotherapies under clinical trial. However, these alternatives may vary in efficacy and side effect profile and are generally used under oncologist guidance[,].\n\nDosage Guidelines for Temozolomide 250 mg\nThe dosage of Temozolomide 250 mg (TMOZOLMIDE 250) by Steris Healthcare is carefully tailored based on the type and stage of cancer, body surface area (BSA), and patient tolerance. The standard regimen for newly diagnosed glioblastoma is an oral dose of 75 mg/m² daily during radiotherapy, followed by maintenance cycles of 150 to 200 mg/m² for 5 days every 28 days. Dose adjustments are common based on blood counts and side effects. Strict adherence to the prescribed dosage schedule and monitoring are critical for safety and efficacy.", "price": 12187.0, "discountamount": 3657.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2229, "imageuri": "https://productimages.withfloats.com/actual/693161477743cf6a1359d094.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/693161477743cf6a1359d094.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-04T10:24:05.165Z", "updatedon": "2026-03-12T08:08:17.975Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//temozolomide-250-mg/2229", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 250", "category": "Oncology", "tags": [ "Temozolomide 250 mg", "cancer", "brain tumors", "cancer cells", "Tumor cells", "chemotherapy", "TMOZOLMIDE 250", "Temozolomide 250 mg capsule uses", "How to take Temozolomide 250 mg correctly", "Temozolomide 250 mg dosage schedule guide", "Temozolomide 250 mg dosage schedule guide", "Temozolomide 250 mg for glioblastoma treatment", "Temozolomide 250 mg empty stomach instructions", "What is Temozolomide 250 mg prescribed for", "Temozolomide 250 mg chemotherapy cycle details", "Temozolomide 250 mg patient information leaflet", "Temozolomide 250 mg storage instructions", "Temozolomide 250 mg manufacturer price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }